[go: up one dir, main page]

NO20000406D0 - Metoder til forbehandling av individer med hyperlipidemi med et flushinhiberende middel i forkant av nikotinsyreterapi - Google Patents

Metoder til forbehandling av individer med hyperlipidemi med et flushinhiberende middel i forkant av nikotinsyreterapi

Info

Publication number
NO20000406D0
NO20000406D0 NO20000406A NO20000406A NO20000406D0 NO 20000406 D0 NO20000406 D0 NO 20000406D0 NO 20000406 A NO20000406 A NO 20000406A NO 20000406 A NO20000406 A NO 20000406A NO 20000406 D0 NO20000406 D0 NO 20000406D0
Authority
NO
Norway
Prior art keywords
hyperlipidemia
pretreatment
individuals
flush
methods
Prior art date
Application number
NO20000406A
Other languages
English (en)
Other versions
NO20000406L (no
Inventor
Eugenio A Cefali
Original Assignee
Kos Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25418033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20000406(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kos Pharma Inc filed Critical Kos Pharma Inc
Publication of NO20000406D0 publication Critical patent/NO20000406D0/no
Publication of NO20000406L publication Critical patent/NO20000406L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20000406A 1997-07-31 2000-01-27 Metoder til forbehandling av individer med hyperlipidemi med et flushinhiberende middel i forkant av nikotinsyreterapi NO20000406L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/903,755 US6469035B1 (en) 1997-07-31 1997-07-31 Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid
PCT/US1998/015987 WO1999006052A1 (en) 1997-07-31 1998-07-31 Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid

Publications (2)

Publication Number Publication Date
NO20000406D0 true NO20000406D0 (no) 2000-01-27
NO20000406L NO20000406L (no) 2000-03-20

Family

ID=25418033

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000406A NO20000406L (no) 1997-07-31 2000-01-27 Metoder til forbehandling av individer med hyperlipidemi med et flushinhiberende middel i forkant av nikotinsyreterapi

Country Status (6)

Country Link
US (1) US6469035B1 (no)
EP (1) EP0999844A1 (no)
AU (1) AU8605298A (no)
CA (1) CA2297756C (no)
NO (1) NO20000406L (no)
WO (1) WO1999006052A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US20010006644A1 (en) * 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
US20040018628A1 (en) * 2001-08-31 2004-01-29 Burd John F. Integrated assay for organ function, drug and / or one or more metabolites
AR041089A1 (es) * 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
US7128806B2 (en) * 2003-10-21 2006-10-31 Applied Materials, Inc. Mask etch processing apparatus
US20080058292A1 (en) * 2003-10-29 2008-03-06 Raif Tawakol Method for increasing HDL and HDL-2b levels
EP1684704A2 (en) * 2003-10-29 2006-08-02 Raif M. Tawakol Compositions and methods for increasing hdl and hdl-2b levels
PL364348A1 (en) 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Application of quaternary pyridine salts as vessel protection agent
EP1919466B9 (en) 2005-07-11 2012-05-16 Cortria Corporation Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative
US20070105793A1 (en) * 2005-11-04 2007-05-10 Curt Hendrix Compositions and methods using nicotinic acid for treatment of hypercholesterolemia, hyperlipidemia nd cardiovascular disease
GB0525461D0 (en) * 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
WO2007103540A2 (en) * 2006-03-08 2007-09-13 Pharmena North America Inc. Combination therapy with non-selective cox inhibitors to prevent cox-related gastric injuries
WO2008091338A1 (en) * 2007-01-23 2008-07-31 Reddy Us Therapeutics, Inc. Methods and compositions for the treatment of insulin resistance, diabetes, and diabetes-associated dyslipidemia
AU2008219599A1 (en) * 2007-03-01 2008-09-04 Concourse Health Sciences Llc Isomers of inositol niacinate and uses thereof
EP2134169A2 (en) 2007-03-09 2009-12-23 Indigene Pharmaceuticals Inc. Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
WO2008127893A1 (en) * 2007-04-04 2008-10-23 Hight H Thomas Niacin-based pharmaceutical compositions
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
EP2180891A4 (en) * 2007-08-13 2010-12-29 Hanall Biopharma Co Ltd COMBINATION PREPARATION WITH HMG COA REDUCTASE INHIBITORS AND ASPIRIN AND METHOD FOR THE PRODUCTION THEREOF
WO2009033072A1 (en) * 2007-09-05 2009-03-12 Raif Tawakol Compositions and methods for controlling cholesterol levels
US20090082315A1 (en) * 2007-09-05 2009-03-26 Raif Tawakol Compositions and Methods for Controlling Cholesterol Levels
US20090130208A1 (en) * 2007-11-21 2009-05-21 Capricorn Pharma Inc. Modified release niacin formulations
RU2010151944A (ru) * 2008-05-20 2012-06-27 Серенис Терапьютикс С.А. (Fr) Ниацин и нспвс для комбинированной терапии
CN102105171A (zh) * 2008-06-02 2011-06-22 雷迪博士实验室有限公司 改进释放烟酸制剂
WO2009149056A2 (en) * 2008-06-02 2009-12-10 Dr. Reddy's Laboratories Ltd. Combinations of niacin and an oxicam
US20100178341A1 (en) * 2008-06-11 2010-07-15 Ranbaxy Laboratories Limited BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR
US20110123609A1 (en) * 2008-07-19 2011-05-26 Sunil Shantwan Borude Multiple unit dosage form of niacin
EP2395837A1 (en) * 2009-01-08 2011-12-21 Anthera Pharmaceuticals, Inc. Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemia
CA2766048A1 (en) 2009-06-25 2010-12-29 Tetra, Sia Novel acetylsalicylic acid salts
EP2588108A2 (en) * 2010-07-02 2013-05-08 Solvotrin Therapeutics Ltd. Treatment for dyslipidemia
JP5726481B2 (ja) * 2010-10-29 2015-06-03 日本精化株式会社 ヒドロキシニコチン酸又はその誘導体を含有する化粧料又は皮膚外用剤
CN107296798A (zh) 2011-10-28 2017-10-27 维塔利斯公司 抗发红组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1704M (fr) * 1961-12-19 1963-02-18 Aec Chim Organ Biolog Médicament anti-allergique et anti-histaminique a base de β-alanine.
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
DE2722113A1 (de) * 1969-07-17 1978-11-02 Christian Brunnengraeber Chem Therapeutisches mittel
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
US4911917A (en) * 1988-06-28 1990-03-27 Hauser-Kuhrts, Inc. Cholesterol-lowering combination comopsitions of magnesium salt and niacin
US5023245A (en) * 1987-11-10 1991-06-11 Hauser-Kuhrts, Inc. Improved niacin formulation
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
CA2003478A1 (en) * 1988-12-12 1990-06-12 Leonard G. Dennick Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
US5126145A (en) * 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament
CA2016467A1 (en) * 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
EP0821587A4 (en) * 1995-04-19 1999-05-19 Lipoprotein Technologies Inc COMPOSITIONS, KITS AND METHODS FOR ADMINISTERING ANTILIPEMICS AND MEDICINES AGAINST PLATELET AGGREGATION

Also Published As

Publication number Publication date
NO20000406L (no) 2000-03-20
EP0999844A1 (en) 2000-05-17
WO1999006052A1 (en) 1999-02-11
US6469035B1 (en) 2002-10-22
WO1999006052A9 (en) 1999-04-29
AU8605298A (en) 1999-02-22
CA2297756C (en) 2008-04-29
CA2297756A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
NO20000406D0 (no) Metoder til forbehandling av individer med hyperlipidemi med et flushinhiberende middel i forkant av nikotinsyreterapi
DK0876332T3 (da) Phenyleddikesyrederivater, fremgangsmåde og mellemprodukter til deres fremstilling og midler indeholdende disse
DE69633333D1 (de) Diphosphonatderivate von therapeutischen substanzen
DK0741694T3 (da) Phenyleddikesyrederivater, fremgangsmåder og mellemprodukter til deres fremstilling og midler indeholdende disse
DE69530004D1 (de) Transdermale verabreichung von apomorphin
FI953981A7 (fi) 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi
SE0400359L (sv) Inhibitorer av små molekyler med rotamasenzymaktivitet
NO933647L (no) Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmåte for deres fremstilling
IT1283931B1 (it) Meccanismo per collegare parti ornamentali di orologi da polso
DK0930091T3 (da) Fremgangsmåde til behandling af röggasser
DK0770687T3 (da) Fremgangsmåde til fremstilling af nicotinsyreamid
ID19754A (id) Metode untuk memproduksi formal siklik secara kontinyu
ATE269349T1 (de) Derivativen von monosacchariden als zelladhäsionshemmer
DK0674089T3 (da) Forbedringer i forbindelse med branddøre
FI896096A7 (fi) Menetelmä piperidiinidionijohdannaisten pelkistämiseksi ja välituotteita
HU9802907D0 (en) Process for restoration from prefabricated wall-elements to erection of buildings, and apparatus for realization of process
EE9700268A (et) Meetod ratseemilise ja enantiomeerse 1-(püridüül)-2-tsükloheksüületüülamiini valmistamiseks
BR9606333A (pt) Metodo de processamento de substâncias residuais metalúrgicas contendo ferro bem como arranjo para executar o dito método
DE69514306D1 (de) Kurzkettige 2-hydroxycarbonsäurederivate von ceramiden
GB2300379B (en) Application of diffractive elements to substrates
DK0744399T3 (da) Omdannelse af substituerede 8-chlorquinoliner til substituerede 8-hydroxyquinoliner
FI940133L (fi) Uudet nikotiinihappojohdannaiset
DK0820252T3 (da) Fremgangsmåde til fremstilling af en elektrode til anbringelse på huden
NO306505B1 (no) Fremgangsmåte for applisering av et spiseredskap til en bærer
DK0971919T3 (da) Fremgangsmåde til fremstilling af 4H-4-oxo-quinolizin-3-carboxylsyrederivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application